Follicular Lymphoma, Grade III
2 clinical trials · Condition
◉ Watch Follicular Lymphoma, Grade III
| Record | Firm | Date |
|---|---|---|
| Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL (NCT02393157) | New York Medical College | 2015-08-21 |
Track Follicular Lymphoma, Grade III automatically
Every clearance here is in the API, with alerts when new ones post.